Cargando…
Flow Cytometric Clinical Immunomonitoring Using Peptide–MHC Class II Tetramers: Optimization of Methods and Protocol Development
With the advent of novel strategies to induce tolerance in autoimmune and autoimmune-like conditions, clinical trials of antigen-specific tolerizing immunotherapy have become a reality. Besides safety, it will be essential to gather mechanistic data on responding CD4(+) T cells to assess the effects...
Autores principales: | Jansen, Diahann T. S. L., Ramnoruth, Nishta, Loh, Khai L., Rossjohn, Jamie, Reid, Hugh H., Nel, Hendrik J., Thomas, Ranjeny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786526/ https://www.ncbi.nlm.nih.gov/pubmed/29403492 http://dx.doi.org/10.3389/fimmu.2018.00008 |
Ejemplares similares
-
Evaluation of a fit-for-purpose assay to monitor antigen-specific functional CD4+ T-cell subpopulations in rheumatoid arthritis using flow cytometry–based peptide-MHC class-II tetramer staining
por: Patel, Swati, et al.
Publicado: (2021) -
Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 Diabetes
por: Musthaffa, Yassmin, et al.
Publicado: (2020) -
Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers
por: James, Eddie A., et al.
Publicado: (2009) -
Development of the automated immunomonitoring system
por: Osawa, Ryuji, et al.
Publicado: (2014) -
From Immunomonitoring to Immune Intervention
por: Toubert, Antoine, et al.
Publicado: (2015)